Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review
Authors
Keywords
COVID-19, ACE2 receptors, hrsACE2, ACE inhibitors, RAS, AT, 1, R blocker
Journal
Journal of Pharmaceutical Analysis
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-17
DOI
10.1016/j.jpha.2021.12.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble ACE2 as a potential therapy for COVID-19
- (2021) Sudarshan Krishnamurthy et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Hypertension, a Moving Target in COVID-19
- (2021) Carmine Savoia et al. CIRCULATION RESEARCH
- Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2
- (2021) Sandeep Singh et al. HYPERTENSION
- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Preventing a covid-19 pandemic
- (2020) John Watkins BMJ-British Medical Journal
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
- (2020) James H Diaz JOURNAL OF TRAVEL MEDICINE
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Vaccine designers take first shots at COVID-19
- (2020) Jon Cohen SCIENCE
- Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
- (2020) Changhai Lei et al. Nature Communications
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- ACE2 and COVID-19 and the resulting ARDS
- (2020) Xiaoqing Zhang et al. POSTGRADUATE MEDICAL JOURNAL
- The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis
- (2020) Kunihiro Matsushita et al. Global Heart
- Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill
- (2019) Laurent Bitker et al. CRITICAL CARE CLINICS
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile–Induced Abdominal Aortic AneurysmNovelty and Significance
- (2017) Tatsuo Kawai et al. HYPERTENSION
- Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
- (2017) Ratnadeep Basu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
- (2017) Lauren G. Gilstrap et al. Journal of the American Heart Association
- Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin IINovelty and Significance
- (2016) Takehiko Takayanagi et al. HYPERTENSION
- Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
- (2016) Hongjing Gu et al. Scientific Reports
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
- (2014) Matthew R. Deshotels et al. HYPERTENSION
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2
- (2012) Anna-Winona Struck et al. ANTIVIRAL RESEARCH
- Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
- (2012) E. M. Mortensen et al. CLINICAL INFECTIOUS DISEASES
- Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63
- (2012) R. Dijkman et al. JOURNAL OF GENERAL VIROLOGY
- Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
- (2010) Keiji Kuba et al. PHARMACOLOGY & THERAPEUTICS
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
- (2009) Hong Peng Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started